Literature DB >> 6308990

High-resolution CT investigation of nonchromaffin paragangliomas of the temporal bone.

A Valavanis, O Schubiger, M Oguz.   

Abstract

Twenty-six cases of surgically verified nonchromaffin paragangliomas (NCPs) of the temporal bone were investigated by contrast-enhanced, thin-section, multiplanar high-resolution computed tomography (CT). Based on the high-resolution CT findings the tumors were classified according to a recently introduced surgical classification of NCP into four main types (A, B, C1-C3, and D1-D3). With high-resolution CT tumors were correctly classified in all cases, as was shown with intraoperative correlation. On the basis of these findings, high-resolution CT should replace conventional tomography and should be regarded as complementary to selective angiography in the preoperative evaluation of NCP.

Entities:  

Mesh:

Year:  1983        PMID: 6308990      PMCID: PMC8334878     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  5 in total

Review 1.  Head and neck imaging.

Authors:  W P Dillon
Journal:  AJNR Am J Neuroradiol       Date:  2000-01       Impact factor: 3.825

2.  Differential diagnosis of jugular foramen lesions.

Authors:  Thomas J Vogl; Sotirios Bisdas
Journal:  Skull Base       Date:  2009-01

3.  Glomus vagale tumour, can it be diagnosed only on sonography?

Authors:  Shuchi Bhatt; Pooja Verma; Neha Meena; Anupama Tandon; Nadeem Tanveer; Divya Bansal
Journal:  J Ultrasound       Date:  2017-01-13

4.  Temporal bone fractures and their complications. Examination with high resolution CT.

Authors:  O Schubiger; A Valavanis; G Stuckmann; F Antonucci
Journal:  Neuroradiology       Date:  1986       Impact factor: 2.804

Review 5.  Neuroendocrine tumours of the head and neck: anatomical, functional and molecular imaging and contemporary management.

Authors:  Navaraj Subedi; Robin Prestwich; Fahmid Chowdhury; Chirag Patel; Andrew Scarsbrook
Journal:  Cancer Imaging       Date:  2013-10-04       Impact factor: 3.909

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.